Carcinoma, Hepatocellular  >>  TheraSphere (yttrium 90 microspheres)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraSphere (yttrium 90 microspheres) / Boston Scientific
NCT01556282: TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis

Completed
N/A
35
US
TheraSphere, There are no other names for this device.
Emory University
Liver Cancer, Portal Vein Thrombosis
01/14
01/14
NCT00589030: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

No Longer Available
N/A
US
brachytherapy, yttrium Y 90 glass microspheres
City of Hope Medical Center
Liver Cancer
09/14
09/14
NCT00701168: Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

No Longer Available
N/A
US
yttrium Y 90 microspheres (Therasphere®)
Leo W. Jenkins Cancer Center
Carcinoma, Hepatocellular, Neoplasm Metastasis
 
 

Download Options